Skip to main content
NCBI home page
British Heart Journal logoLink to British Heart Journal
. 1990 Apr;63(4):231–233. doi: 10.1136/hrt.63.4.231

Reduction of factor VII coagulant activity (VIIC), a risk factor for ischaemic heart disease, by fixed dose warfarin: a double blind crossover study.

L Poller 1, P K MacCallum 1, J M Thomson 1, W Kerns 1
PMCID: PMC1024437  PMID: 2186769

Abstract

An increase in factor VII coagulant activity is known to be an important risk factor for ischaemic heart disease. Four hundred and eight healthy male Post Office workers were screened in an occupational survey. Sixty eight (16.5%) of these had values of factor VII coagulant activity greater than 1.0 SD above the age related mean. A randomised double-blind crossover study was undertaken to investigate the effect of a fixed daily minidose of warfarin (1 mg) on the high activities of factor VII in these men. Forty two agreed to enter the study and 40 completed it. Their mean factor VII coagulant activity before warfarin treatment was 135.9%. Treatment with a fixed minidose of warfarin significantly reduced factor VII coagulant activity to 124.6%; there was no change on placebo. The prothrombin time was also significantly prolonged on active treatment although all the results remained within the normal range. These findings suggested a fixed minidose warfarin regime might be useful in the primary prevention of ischaemic heart disease by reducing high activities of factor VII.

Full text

PDF
231

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ALEXANDER B., MEYERS L., KENNY J., GOLDSTEIN R., GUREWICH V., GRINSPOON L. Blood coagulation in pregnancy: proconvertin and prothrombin, and the hypercoagulable state. N Engl J Med. 1956 Feb 23;254(8):358–363. doi: 10.1056/NEJM195602232540803. [DOI] [PubMed] [Google Scholar]
  2. Balleisen L., Bailey J., Epping P. H., Schulte H., van de Loo J. Epidemiological study on factor VII, factor VIII and fibrinogen in an industrial population: I. Baseline data on the relation to age, gender, body-weight, smoking, alcohol, pill-using, and menopause. Thromb Haemost. 1985 Aug 30;54(2):475–479. [PubMed] [Google Scholar]
  3. Bern M. M., Bothe A., Jr, Bistrian B., Champagne C. D., Keane M. S., Blackburn G. L. Prophylaxis against central vein thrombosis with low-dose warfarin. Surgery. 1986 Feb;99(2):216–221. [PubMed] [Google Scholar]
  4. Brozovic M., Stirling Y., Harricks C., North W. R., Meade T. W. Factor VII in an industrial population. Br J Haematol. 1974 Nov;28(3):381–391. doi: 10.1111/j.1365-2141.1974.tb00819.x. [DOI] [PubMed] [Google Scholar]
  5. Constantino M., Merskey C., Kudzma D. J., Zucker M. B. Increased activity of vitamin K-dependent clotting factors in human hyperlipoproteinaemia - association with cholesterol and triglyceride levels. Thromb Haemost. 1977 Aug 31;38(2):465–474. [PubMed] [Google Scholar]
  6. Fuller J. H., Keen H., Jarrett R. J., Omer T., Meade T. W., Chakrabarti R., North W. R., Stirling Y. Haemostatic variables associated with diabetes and its complications. Br Med J. 1979 Oct 20;2(6196):964–966. doi: 10.1136/bmj.2.6196.964. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Hull R., Hirsh J., Jay R., Carter C., England C., Gent M., Turpie A. G., McLoughlin D., Dodd P., Thomas M. Different intensities of oral anticoagulant therapy in the treatment of proximal-vein thrombosis. N Engl J Med. 1982 Dec 30;307(27):1676–1681. doi: 10.1056/NEJM198212303072704. [DOI] [PubMed] [Google Scholar]
  8. Meade T. W., Haines A. P., Imeson J. D., Stirling Y., Thompson S. G. Menopausal status and haemostatic variables. Lancet. 1983 Jan 1;1(8314-5):22–24. doi: 10.1016/s0140-6736(83)91562-3. [DOI] [PubMed] [Google Scholar]
  9. Meade T. W., Mellows S., Brozovic M., Miller G. J., Chakrabarti R. R., North W. R., Haines A. P., Stirling Y., Imeson J. D., Thompson S. G. Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study. Lancet. 1986 Sep 6;2(8506):533–537. doi: 10.1016/s0140-6736(86)90111-x. [DOI] [PubMed] [Google Scholar]
  10. Meade T. W., North W. R., Chakrabarti R., Stirling Y., Haines A. P., Thompson S. G., Brozovié M. Haemostatic function and cardiovascular death: early results of a prospective study. Lancet. 1980 May 17;1(8177):1050–1054. doi: 10.1016/s0140-6736(80)91498-1. [DOI] [PubMed] [Google Scholar]
  11. Meade T. W., Wilkes H. C., Stirling Y., Brennan P. J., Kelleher C., Browne W. Randomized controlled trial of low dose warfarin in the primary prevention of ischaemic heart disease in men at high risk: design and pilot study. Eur Heart J. 1988 Aug;9(8):836–843. doi: 10.1093/oxfordjournals.eurheartj.a062576. [DOI] [PubMed] [Google Scholar]
  12. Miller G. J., Martin J. C., Webster J., Wilkes H., Miller N. E., Wilkinson W. H., Meade T. W. Association between dietary fat intake and plasma factor VII coagulant activity--a predictor of cardiovascular mortality. Atherosclerosis. 1986 Jun;60(3):269–277. doi: 10.1016/0021-9150(86)90174-7. [DOI] [PubMed] [Google Scholar]
  13. Miller G. J., Walter S. J., Stirling Y., Thompson S. G., Esnouf M. P., Meade T. W. Assay of factor VII activity by two techniques: evidence for increased conversion of VII to alpha VIIa in hyperlipidaemia, with possible implications for ischaemic heart disease. Br J Haematol. 1985 Feb;59(2):249–258. doi: 10.1111/j.1365-2141.1985.tb02991.x. [DOI] [PubMed] [Google Scholar]
  14. POLLER L. Thrombosis and factor VII activity. J Clin Pathol. 1957 Nov;10(4):348–350. doi: 10.1136/jcp.10.4.348. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Poller L., McKernan A., Thomson J. M., Elstein M., Hirsch P. J., Jones J. B. Fixed minidose warfarin: a new approach to prophylaxis against venous thrombosis after major surgery. Br Med J (Clin Res Ed) 1987 Nov 21;295(6609):1309–1312. doi: 10.1136/bmj.295.6609.1309. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Poller L., Taberner D. A. Dosage and control of oral anticoagulants: an international collaborative survey. Br J Haematol. 1982 Jul;51(3):479–485. doi: 10.1111/j.1365-2141.1982.tb02805.x. [DOI] [PubMed] [Google Scholar]
  17. Poller L., Thomson J. M., Sear C. H., Thomas W. Identification of a congenital defect of factor VII in a colony of beagle dogs: the clinical use of the plasma. J Clin Pathol. 1971 Oct;24(7):626–632. doi: 10.1136/jcp.24.7.626. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Stirling Y., Woolf L., North W. R., Seghatchian M. J., Meade T. W. Haemostasis in normal pregnancy. Thromb Haemost. 1984 Oct 31;52(2):176–182. [PubMed] [Google Scholar]
  19. THOMSON J. M., POLLER L. ORAL CONTRACEPTIVE HORMONES AND BLOOD COAGULABILITY. Br Med J. 1965 Jul 31;2(5456):270–273. doi: 10.1136/bmj.2.5456.270. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Heart Journal are provided here courtesy of BMJ Publishing Group

RESOURCES